Researchers identify women with twice the risk of cancer in both breasts

by Mayo ClinicCumulative incidence of CBC risk in PV carriers. Cumulative incidence plots for first contralateral breast cancers after primary breast cancer. Cumulative incidence is plotted again

Updated on: February 18,2024

Researchers identify women with twice the risk of cancer in both breasts

by Mayo ClinicCumulative incidence of CBC risk in PV carriers. Cumulative incidence plots for first contralateral breast cancers after primary breast cancer. Cumulative incidence is plotted again

Updated on:February 18,2024

Cooling glioblastoma to room temperature extends survival in preclinical study

by Jenny Owen,Emory UniversityConceptual model of a translational device to deliver cytostatic hypothermia for GBM. Representative diagram of a patient with GBM implanted with an envisioned cyto

Updated on: January 30,2024

Cooling glioblastoma to room temperature extends survival in preclinical study

by Jenny Owen,Emory UniversityConceptual model of a translational device to deliver cytostatic hypothermia for GBM. Representative diagram of a patient with GBM implanted with an envisioned cyto

Updated on:January 30,2024

'Dead zone' within tumor promotes cancer spread, helped by a protein secreted by cancer cells

by Diana Mapes, Fred Hutchinson Cancer CenterFred Hutch's Ami Yamamoto, foreground, at work in the lab of Dr. Kevin Cheung (seen in background). Yamamoto's investigation of the necrotic core o

Updated on: February 18,2024

'Dead zone' within tumor promotes cancer spread, helped by a protein secreted by cancer cells

by Diana Mapes, Fred Hutchinson Cancer CenterFred Hutch's Ami Yamamoto, foreground, at work in the lab of Dr. Kevin Cheung (seen in background). Yamamoto's investigation of the necrotic core o

Updated on:February 18,2024

Enhanced recovery program shown to successfully reduce opioid use after pancreatic cancer surgery

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainBy improving hospital care pathways, researchers from The University of Texas MD Anderson Cancer Center succes

Updated on: January 30,2024

Enhanced recovery program shown to successfully reduce opioid use after pancreatic cancer surgery

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainBy improving hospital care pathways, researchers from The University of Texas MD Anderson Cancer Center succes

Updated on:January 30,2024

Mind-body practice of qigong can improve cancer-related fatigue, finds study

by Joshua Speiser,Brown UniversityCredit: Pixabay/CC0 Public DomainA study led by Brown University researchers has found that a low-impact, meditative movement program involving qigong was as ef

Updated on: January 23,2024

Mind-body practice of qigong can improve cancer-related fatigue, finds study

by Joshua Speiser,Brown UniversityCredit: Pixabay/CC0 Public DomainA study led by Brown University researchers has found that a low-impact, meditative movement program involving qigong was as ef

Updated on:January 23,2024

New compounds target and kill brain cancer cells after being energized by low X-ray dose

by Nanyang Technological UniversityResearch fellow Dr Huang Jingsheng from NTU Singapore's School of Chemistry, Chemical Engineering and Biotechnology preparing new anti-brain cancer compound

Updated on: March 05,2024

New compounds target and kill brain cancer cells after being energized by low X-ray dose

by Nanyang Technological UniversityResearch fellow Dr Huang Jingsheng from NTU Singapore's School of Chemistry, Chemical Engineering and Biotechnology preparing new anti-brain cancer compound

Updated on:March 05,2024

Drug combo ups progression-free survival for metastatic prostate cancer

by Elana GotkineFor patients with metastatic castration-resistant prostate cancer (mCRPC), talazoparib plus enzalutamide results in improvement in radiographic progression-free survival (rPFS), accord

Updated on: January 30,2024

Drug combo ups progression-free survival for metastatic prostate cancer

by Elana GotkineFor patients with metastatic castration-resistant prostate cancer (mCRPC), talazoparib plus enzalutamide results in improvement in radiographic progression-free survival (rPFS), accord

Updated on:January 30,2024

Research team leads adaptive, efficient multi-arm phase 2 clinical trial for glioblastoma

by Dana-Farber Cancer InstituteGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0An innovative phase 2 clinical trial led by Dana-Farber Cancer Institute, in collaboration with 10 maj

Updated on: May 27,2024

Research team leads adaptive, efficient multi-arm phase 2 clinical trial for glioblastoma

by Dana-Farber Cancer InstituteGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0An innovative phase 2 clinical trial led by Dana-Farber Cancer Institute, in collaboration with 10 maj

Updated on:May 27,2024

Study shows breast cancer overdiagnosis common among older women

byAmerican College of PhysiciansCredit: Pixabay/CC0 Public DomainA study of more than 50,000 women found that continued breast cancer screening after age 70 was associated with a greater inciden

Updated on: January 22,2024

Study shows breast cancer overdiagnosis common among older women

byAmerican College of PhysiciansCredit: Pixabay/CC0 Public DomainA study of more than 50,000 women found that continued breast cancer screening after age 70 was associated with a greater inciden

Updated on:January 22,2024

'Collateral damage' from normal cell function may cause mutations that play a role in cancer

by Wellcome Trust Sanger InstituteSpatial distribution of APOBEC-positive crypts. APOBEC-positive crypts and their surrounding crypts before microdissection with their SBS mutational spectrums. S

Updated on: February 18,2024

'Collateral damage' from normal cell function may cause mutations that play a role in cancer

by Wellcome Trust Sanger InstituteSpatial distribution of APOBEC-positive crypts. APOBEC-positive crypts and their surrounding crypts before microdissection with their SBS mutational spectrums. S

Updated on:February 18,2024

Researchers gain structural insights into the immune modulator Siglec-15 and its interaction with T cells

by CIC bioGUNEa Cartoon and surface representation of two views of the crystal structure of Siglec-15 in complex with anti-Siglec-15 5G12 Fab. 5G12 is composed of a heavy chain (HC) (in orange) and a

Updated on: February 18,2024

Researchers gain structural insights into the immune modulator Siglec-15 and its interaction with T cells

by CIC bioGUNEa Cartoon and surface representation of two views of the crystal structure of Siglec-15 in complex with anti-Siglec-15 5G12 Fab. 5G12 is composed of a heavy chain (HC) (in orange) and a

Updated on:February 18,2024

Re-engineered, blue light-activated immune cells penetrate and kill solid tumors

byPennsylvania State UniversityMyeloid immune cells alongsidered blood cells in an electron micrograph of human blood. Credit: National Cancer InstituteImmunotherapies that mobilize a pati

Updated on: November 10,2024

Re-engineered, blue light-activated immune cells penetrate and kill solid tumors

byPennsylvania State UniversityMyeloid immune cells alongsidered blood cells in an electron micrograph of human blood. Credit: National Cancer InstituteImmunotherapies that mobilize a pati

Updated on:November 10,2024